Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study

Author:De Stefano, Nicola   Achiron, Anat   Barkhof, Frederik   Chan, Andrew   Derfuss, Tobias   Hodgkinson, Suzanne   Leocani, Letizia   Montalban, Xavier   Prat, Alexandre   Schmierer, Klaus   Sellebjerg, Finn   Vermersch, Patrick   Wiendl, Heinz   Keller, Birgit   Smyk, Andrzej   Gardner, Lidia   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.018  

Author Institution:Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy  Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel  Department of Radiology, VU University Medical Center, Amsterdam, Netherlands  Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland  Department of Neurology, University Hospital Basel, Basel, Switzerland  Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia  Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy  Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain  Department of Neurosciences, Université de Montréal, Montreal, QC, Canada  The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom  Danish MS Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark  Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France  Department of Neurology, Institute of Translational Neurology, University of Münster, Muenster, Germany  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  EMD Serono Research and Development Institute, Inc., Billerica, MA, USA , Billerica, MA  

Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database

Author:Bove, Riley   Pia Amato, Maria   Dobson, Ruth   M. Krysko, Kristen   Stoll, Sharon   Vukusic, Sandra   Yamout, Bassem   Zielman, Ronald   Krishna Gummuluri, Swetha   Jehl, Valentine   Schulze Topphoff, Ulf   Sullivan, Roseanne   Fantaccini, Simone   Hellwig, Kerstin   

Session Name:P9: MS Special Populations  

Topic:MS and Inflammatory Disease  

Program Number:P9.014  

Author Institution:UCSF Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA, Berkeley, CA  Department NEUROFARBA, University of Florence, Florence, Italy  IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Florence, Italy  Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom  Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, London, United Kingdom  Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada  Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Toronto, ON, Canada  Department of Neurology, Yale University, New Haven, Connecticut, USA, New Haven, CT  Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France  Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Observatoire Français de la Sclérose en Plaques, Lyon, France  Université Claude Bernard Lyon 1, Villeurbanne, France, BRON Cedex, France  American University of Beirut Medical Center, Beirut, Lebanon  Harley Street Medical Centre, Abu Dhabi, UAE, Beirut, Lebanon  Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands  Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India  Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland  Novartis Pharma GmbH, Germany, Nuernberg, Germany  Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ  Novartis Pharma A.G. Basel, Switzerland, Binningen, Switzerland  St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany, Bochum, Germany